These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 36474082

  • 1. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
    Wang K, Yang R, Chen TT, Qin MR, Wang P, Kong MW.
    Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
    [Abstract] [Full Text] [Related]

  • 2. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
    Yi P, Zhang Z, Huang S, Huang J, Peng W, Yang J.
    Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
    [Abstract] [Full Text] [Related]

  • 3. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice.
    Jiao YN, Zhang JS, Qiao WJ, Tian SY, Wang YB, Wang CY, Zhang YH, Zhang Q, Li W, Min DY, Wang ZY.
    Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280
    [Abstract] [Full Text] [Related]

  • 4. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro.
    Yan C, Yang S, Shao S, Zu R, Lu H, Chen Y, Zhou Y, Ying X, Xiang S, Zhang P, Li Z, Yuan Y, Zhang Z, Wang P, Xie Z, Wang W, Ma H, Sun Y.
    J Ethnopharmacol; 2024 May 23; 326():117915. PubMed ID: 38360383
    [Abstract] [Full Text] [Related]

  • 5. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway.
    Shan X, Lv S, Huang P, Zhang W, Jin C, Liu Y, Li Y, Jia Y, Chu X, Peng C, Zhang C.
    Mol Neurobiol; 2024 Apr 23; 61(4):2297-2312. PubMed ID: 37874481
    [Abstract] [Full Text] [Related]

  • 6. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z, Xu J, Ma S, Lin N, Hou M, Wei M, Li T, Shi J.
    Comb Chem High Throughput Screen; 2022 Apr 23; 25(10):1785-1804. PubMed ID: 35616676
    [Abstract] [Full Text] [Related]

  • 7. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.
    Luo Y, Li D, Liao Y, Cai C, Wu Q, Ke H, Liu X, Li H, Hong H, Xu Y, Wang Q, Fang J, Fang S.
    Front Pharmacol; 2020 Apr 23; 11():381. PubMed ID: 32317964
    [Abstract] [Full Text] [Related]

  • 8. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F, He K, Guan Y, Yang X, Chen Y, Sun M, Qiu X, Yan F, Huang H, Yao L, Liu B, Huang L.
    J Ethnopharmacol; 2020 Sep 15; 259():112940. PubMed ID: 32389853
    [Abstract] [Full Text] [Related]

  • 9. [Network pharmacology-based study of the therapeutic mechanism of resveratrol for Alzheimer's disease].
    Fang Y, Su Z, Si W, Liu Y, Li J, Zeng P.
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan 30; 41(1):10-19. PubMed ID: 33509748
    [Abstract] [Full Text] [Related]

  • 10. Network pharmacology analysis and experimental validation of Anemarrhenae Rhizoma in treating Alzheimer's disease.
    Li D, Hu Y, Liu X, Yu G.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec 13; 53(1):84-97. PubMed ID: 38105702
    [Abstract] [Full Text] [Related]

  • 11. Elucidating the therapeutic mechanism of Hengqing II decoction in Alzheimer's disease using network pharmacology and molecular docking techniques.
    Wang Y, Jiang J, Chen S, Chen Q, Yan X, Shen X.
    Fitoterapia; 2024 Apr 13; 174():105860. PubMed ID: 38367649
    [Abstract] [Full Text] [Related]

  • 12. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
    Chu H, Zhang A, Han Y, Lu S, Kong L, Han J, Liu Z, Sun H, Wang X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar 15; 1015-1016():50-61. PubMed ID: 26896572
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome via network pharmacology and molecular docking analysis.
    Zheng R, Shi S, Zhang Q, Yuan S, Guo T, Guo J, Jiang P.
    Front Cell Infect Microbiol; 2023 Mar 15; 13():1140945. PubMed ID: 37009506
    [Abstract] [Full Text] [Related]

  • 14. Kai-xin-san improves cognitive impairment in D-gal and Aβ25-35 induced ad rats by regulating gut microbiota and reducing neuronal damage.
    Wang H, Zhou L, Zheng Q, Song Y, Huang W, Yang L, Xiong Y, Cai Z, Chen Y, Yuan J.
    J Ethnopharmacol; 2024 Jul 15; 329():118161. PubMed ID: 38599474
    [Abstract] [Full Text] [Related]

  • 15. Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway.
    Guo S, Wang J, Xu H, Rong W, Gao C, Yuan Z, Xie F, Bi K, Zhang Z, Li Q.
    Oxid Med Cell Longev; 2019 Jul 15; 2019():9096409. PubMed ID: 31354916
    [Abstract] [Full Text] [Related]

  • 16. Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway.
    Shan X, Tao W, Li J, Tao W, Li D, Zhou L, Yang X, Dong C, Huang S, Chu X, Zhang C.
    J Ethnopharmacol; 2024 Jul 15; 329():118145. PubMed ID: 38582153
    [Abstract] [Full Text] [Related]

  • 17. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice.
    Xu YM, Lu FM, Xu HC, Zhang J, Hei SY, Qiu YH, Cai YF, Zhang SJ, Zhao M.
    Rejuvenation Res; 2023 Jun 15; 26(3):105-115. PubMed ID: 37073462
    [Abstract] [Full Text] [Related]

  • 18. Apigenin inhibits proliferation and differentiation of cardiac fibroblasts through AKT/GSK3β signaling pathway.
    Kan H, Wang P, Yang Y, Jia H, Liu A, Wang M, Ouyang C, Yang X.
    J Ethnopharmacol; 2024 Nov 15; 334():118518. PubMed ID: 38964628
    [Abstract] [Full Text] [Related]

  • 19. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
    Shang B, Jia S, Zhang T, Gao F, Lu M, Chen K, Jiao J, Dai Z, Zeng Q, Xu B, Lei H.
    J Ethnopharmacol; 2024 Mar 25; 322():117652. PubMed ID: 38151178
    [Abstract] [Full Text] [Related]

  • 20. Role of corn silk for the treatment of Alzheimer's disease: A mechanism research based on network pharmacology combined with molecular docking and experimental validation.
    Tao TZ, Wang L, Liu J.
    Chem Biol Drug Des; 2023 Nov 25; 102(5):1231-1247. PubMed ID: 37563784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.